One-tube SARS-CoV-2 detection platform based on RT-RPA and CRISPR/Cas12a

被引:159
|
作者
Sun, Yangyang [1 ,2 ,3 ,4 ]
Yu, Lei [1 ,2 ,3 ,4 ]
Liu, Chengxi [5 ]
Ye, Shanting [1 ,2 ,3 ,4 ]
Chen, Wei [1 ,2 ,3 ,4 ]
Li, Dechang [6 ]
Huang, Weiren [1 ,2 ,3 ,4 ]
机构
[1] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Urol,Int Canc Ctr, Shenzhen, Peoples R China
[2] Shenzhen Univ, Sch Med, Int Canc Ctr, Shenzhen 518060, Peoples R China
[3] Shantou Univ, Affiliated Hosp 1, Shantou 515041, Peoples R China
[4] Guangdong Key Lab Syst Biol & Synthet Biol Urogen, Shenzhen 518035, Peoples R China
[5] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Key Lab Syst Biomed, Minist Educ, Shanghai 200240, Peoples R China
[6] Yuebei Second Peoples Hosp, Shaoguan 512000, Guangdong, Peoples R China
基金
美国国家科学基金会; 国家重点研发计划; 中国国家自然科学基金;
关键词
COVID-19; SARS-CoV-2; assay; RT-RPA; CRISPR; Cas;
D O I
10.1186/s12967-021-02741-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background COVID-19 has spread rapidly around the world, affecting a large percentage of the population. When lifting certain mandatory measures for an economic restart, robust surveillance must be established and implemented, with nucleic acid detection for SARS-CoV-2 as an essential component. Methods We tried to develop a one-tube detection platform based on RT-RPA (Reverse Transcription and Recombinase Polymerase Isothermal Amplification) and DNA Endonuclease-Targeted CRISPR Trans Reporter (DETECTR) technology, termed OR-DETECTR, to detect SARS-CoV-2. We designed RT-RPA primers of the RdRp and N genes following the SARS-CoV-2 gene sequence. We optimized reaction components so that the detection process could be carried out in one tube. Specificity was demonstrated by detecting nucleic acid samples from pseudoviruses from seven human coronaviruses and Influenza A (H1N1). Clinical samples were used to validate the platform and all results were compared to rRT-PCR. RNA standards and pseudoviruses diluted by different gradients were used to demonstrate the detection limit. Additionally, we have developed a lateral flow assay based on OR-DETECTR for detecting COVID-19. Results The OR-DETECTR detection process can be completed in one tube, which takes approximately 50 min. This method can specifically detect SARS-CoV-2 from seven human coronaviruses and Influenza A (H1N1), with a low detection limit of 2.5 copies/mu l input (RNA standard) and 1 copy/mu l input (pseudovirus). Results of six samples from SARS-CoV-2 patients, eight samples from patients with fever but no SARS-CoV-2 infection, and one mixed sample from 40 negative controls showed that OR-DETECTR is 100% consistent with rRT-PCR. The lateral flow assay based on OR-DETECTR can be used for the detection of COVID-19, and the detection limit is 2.5 copies/mu l input. Conclusions The OR-DETECTR platform for the detection of COVID-19 is rapid, accurate, tube closed, easy-to-operate, and free of large instruments.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] On-Site and Visual Detection of the H5 Subtype Avian Influenza Virus Based on RT-RPA and CRISPR/Cas12a
    Zhou, Xu
    Wang, Siwen
    Ma, Yue
    Jiang, Yongping
    Li, Yanbing
    Shi, Jianzhong
    Deng, Guohua
    Tian, Guobin
    Kong, Huihui
    Wang, Xiurong
    VIRUSES-BASEL, 2024, 16 (05):
  • [22] Establishment of portable Pseudomonas aeruginosa detection platform based on one-tube CRISPR/Cas12a combined with recombinase polymerase amplification technology
    Yang, Haitao
    Liu, Aibo
    Ma, Fenfen
    Gao, Xuzhu
    Wang, Kun
    Wang, Yan
    CLINICA CHIMICA ACTA, 2024, 554
  • [23] Rapid One-Tube RPA-CRISPR/Cas12 Detection Platform for Methicillin-Resistant Staphylococcus aureus
    Li, Yanan
    Shi, Zhonglin
    Hu, Anzhong
    Cui, Junsheng
    Yang, Ke
    Liu, Yong
    Deng, Guoqing
    Zhu, Cancan
    Zhu, Ling
    DIAGNOSTICS, 2022, 12 (04)
  • [24] The development of RT-RPA and CRISPR-Cas12a based assay for sensitive detection of Hirame novirhabdovirus
    Tang, Xiaoqian
    Li, Wenshuo
    Wang, Hongsheng
    Sheng, Xiuzhen
    Xing, Jing
    Chi, Heng
    Guo, Ming
    Zhan, Wenbin
    MICROBIAL PATHOGENESIS, 2024, 196
  • [25] A rapid, specific and ultrasensitive detection of the Chikungunya virus based on RT-RPA:CRISPR/Cas12a one-pot dual mode end-point detection system
    Bhardwaj, Pooja
    Gulafshan, Shahzadi
    Singh, Rajeev
    ANALYTICA CHIMICA ACTA, 2024, 1329
  • [26] Clinical Validation of a Rapid Variant-Proof RT-RPA Assay for the Detection of SARS-CoV-2
    Cherkaoui, Dounia
    Heaney, Judith
    Huang, Da
    Byott, Matthew
    Miller, Benjamin S.
    Nastouli, Eleni
    McKendry, Rachel A.
    DIAGNOSTICS, 2022, 12 (05)
  • [27] Optimization and Benchmarking of RT-LAMP-CRISPR-Cas12a for the Detection of SARS-CoV-2 in Saliva
    Lynch, Courtney R. H.
    Drummond, Revel S. M.
    Jelley, Lauren
    Baker, Lauren
    Smit, Erasmus
    Fleming, Rachel
    Billington, Craig
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [28] Rapid detection of SARS-CoV-2 with CRISPR-Cas12a
    Xiong, Dan
    Dai, Wenjun
    Gong, Jiaojiao
    Li, Guande
    Liu, Nansong
    Wu, Wei
    Pan, Jiaqiang
    Chen, Chen
    Jiao, Yingzhen
    Deng, Huina
    Ye, Junwei
    Zhang, Xuanxuan
    Huang, Huiling
    Li, Qianyun
    Xue, Liang
    Zhang, Xiuming
    Tang, Guanghui
    PLOS BIOLOGY, 2020, 18 (12)
  • [29] RT-LAMP CRISPR-Cas12/13-Based SARS-CoV-2 Detection Methods
    Selvam, Kasturi
    Najib, Mohamad Ahmad
    Khalid, Muhammad Fazli
    Mohamad, Suharni
    Palaz, Fahreddin
    Ozsoz, Mehmet
    Aziah, Ismail
    DIAGNOSTICS, 2021, 11 (09)
  • [30] RT-RPA-Cas12a-based assay facilitates the discrimination of SARS-CoV-2 variants of concern
    Tang, Guiyue
    Zhang, Zilong
    Tan, Wei
    Long, Fei
    Sun, Jingxian
    Li, Yingying
    Zou, Siwei
    Yang, Yujiao
    Cai, Kezhu
    Li, Shenwei
    Wang, Zhiyi
    Liu, Jiakun
    Mao, Guobing
    Ma, Yingxin
    Zhao, Guo-Ping
    Tian, Zhen-Gan
    Zhao, Wei
    SENSORS AND ACTUATORS B-CHEMICAL, 2023, 381